Fully diluted revenue is another metric that shows that $INJ is one of the biggest blockchains in earnings.

And the numbers make the comparison interesting.

Currently, @Injective has the leading Revenue/FDV ratio of 0.95, ahead of:

→ Solana at 0.83
→ Arbitrum at 0.78
→ Ethereum at 0.11
→ Sui at 0.08
→ Avalanche at 0.06

This gives Injective about 14% advantage over Solana, 20%+ over Arbitrum and almost 8x over Ethereum on this measure.

Why is this important?

Revenue / valuation gives a sense of how well a network is doing in terms of onchain revenue over the fully diluted market value. While not all methods are equal in assessing a blockchain, it provides an additional perspective beyond the noise and sentiment in the market.

What makes the $INJ story even more interesting is the Community BuyBack. Injective's ecosystem revenue is used to acquire and burn INJ to decrease the token supply in a continuous manner.

With the ongoing growth of tokenization projects and the introduction of new products, revenue might even play an even bigger role in the Injective thesis.

The big question now is what to do with that revenue to increase it from here. 🥷

#injective #INJ #defi #crypto #blockchain